immunotherapies; cancers; infectious diseases; hepatitis B; liver cancer
Transgene is a biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancers and infectious diseases. Transgene’s programs utilize well-tolerated viruses with the goal of indirectly or directly killing infected or cancerous cells. Present in China since 2010, Transgene, in collaboration with Tasly Pharmaceuticals Group Co., Ltd., develops new approaches in immunotherapy for cancers and chronic diseases with a high prevalence in this country: hepatitis B, liver cancer…The Company coordinates the Sino-European IMMUNOCAN program, which aims at creating a reference research center in Asia, focused on cancer treatment enhancement through a personalized medicine program (predictive and prognosis biomarkers identification).
Present in China since 2010, Transgene, in collaboration with Tasly Pharmaceuticals Group Co., Ltd., develops new approaches in immunotherapy for cancers and chronic diseases with a high prevalence in this country: hepatitis B, liver cancer…The Company coordinates the Sino-European IMMUNOCAN program, which aims at creating a reference research center in Asia, focused on cancer treatment enhancement through a personalized medicine program (predictive and prognosis biomarkers identification).
